Stock Market & Financial Investment News

News Breaks October 16, 2012 07:10 EDT NPSP NPS Pharmaceuticals says Nasdaq halts trading, FDA to review Gattex NDA NPS Pharmaceuticals announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee is meeting today to review Gattex, a novel, recombinant analog of human glucagon-like peptide 2 being developed for the treatment of adults with short bowel syndrome. News For NPSP From The Last 14 Days Check below for free stories on NPSP the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 17:59 EDT NPSP NPS Pharmaceuticals 6M share Secondary priced at $14.53 Subscribe for More Information 07:34 EDT NPSP UBS to host a conference Subscribe for More Information May 20, 2013 16:22 EDT NPSP NPS Pharmaceuticals files to sell 6M shares of common stock J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers for the proposed offering. May 9, 2013 08:16 EDT NPSP NPS Pharmaceuticals reports Q1 EPS (9c), consensus (13c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.